U.S. Alliance Pharma Acquires U.K.-Based Lgc’S Drug Development Solutions (Dds) Business
Acquiring Company
Alliance Pharma plc
Acquired Company
Drug Development Solutions (An LGC Business Unit)
Description
Alliance Pharma (Alliance), a U.S. leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, today closed on the purchase of Drug Development Solutions (DDS), a U.K.-based bioanalytical and material science testing contract research organization (CRO), from LGC. Ampersand Capital Partners, a global healthcare private equity firm, and KKR & Co. Inc. (KKR) (NYSE:KKR), a leading global investment firm, are equal shareholders in the combined company. This transaction expands bioanalytical, analytical material testing and laboratory capabilities internationally for the biopharma and pharma industry, including areas of cell and gene therapy, next-generation biologics, material sciences and protein characterization.
Other recent acquisitions in Professional Services and Science And Engineering
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bristol Myers Squibb And Turning Point Therapeutics Announce Expiration Of Hsr Act Waiting Period And Clearance From Federal Cartel Office Of Germany Related To Pending Acquisition Of Turning Point Therapeutics (August 16, 2022)
- Bristol Myers Squibb Completes Acquisition Of Turning Point Therapeutics, Expanding Precision Oncology Portfolio (August 17, 2022)
- Bristol Myers Squibb To Acquire Turning Point Therapeutics, A Leading Precision Oncology Company (June 3, 2022)
- Regeneron Completes Acquisition Of Checkmate Pharmaceuticals (May 31, 2022)
- Conmed Completes Acquisition Of Biorez, Inc. (August 9, 2022)
- Catalent To Acquire Metrics Contract Services For $475 Million To Expand High-Potent Capabilities And Oral Development And Manufacturing Capacity, $475M (August 9, 2022)
Who to call at Alliance Pharma plc, and when
When Alliance Pharma plc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Alliance Pharma plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alliance Pharma plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alliance Pharma plc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alliance Pharma plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Drug Development Solutions (An LGC Business Unit)?
Drug Development Solutions (An LGC Business Unit) was acquired by Alliance Pharma plc. The deal was reported on July 13, 2022. Alliance Pharma plc is a UK listed international consumer healthcare company targeting the markets of France, the US, Germany, China, and the UK. Alliance Pharma plc is privately held and operates in Biotechnology.
When did Alliance Pharma plc acquire Drug Development Solutions (An LGC Business Unit)?
Alliance Pharma plc's acquisition of Drug Development Solutions (An LGC Business Unit) was reported on July 13, 2022. Alliance Pharma (Alliance), a U.S. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Drug Development Solutions (An LGC Business Unit) do?
It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.